
VYLUMA TO PRESENT AT THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Jan 5, 2023 | Vyluma
Vyluma, a biopharmaceutical company developing multiple assets for the treatment of refractive errors, today announced it will participate in the 41st annual J.P. Morgan Healthcare Conference, taking place January 9-12, 2023 in San Francisco, Calif.